Akero Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Akero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akero Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akero Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.6M | 153k | 23.35 |
| 2023-09-30 | $36M | 715k | 50.58 |
| 2023-06-30 | $16M | 337k | 46.69 |
| 2023-03-31 | $7.2M | 185k | 38.79 |
| 2022-12-31 | $10M | 183k | 55.47 |
| 2022-06-30 | $2.3M | 235k | 9.65 |
| 2022-03-31 | $647k | 46k | 14.11 |
| 2021-12-31 | $996k | 48k | 20.83 |
| 2021-03-31 | $1.4M | 48k | 28.96 |
| 2020-12-31 | $1.2M | 47k | 26.29 |
| 2020-09-30 | $1.8M | 58k | 31.57 |
| 2020-06-30 | $1.6M | 63k | 24.74 |
| 2020-03-31 | $1.1M | 51k | 21.15 |
| 2019-12-31 | $2.4M | 106k | 22.50 |
| 2019-09-30 | $1.9M | 84k | 22.75 |